Followers | 15 |
Posts | 151 |
Boards Moderated | 0 |
Alias Born | 06/20/2020 |
Wednesday, February 03, 2021 11:34:29 AM
Dec 14, 2020 0.1450 0.1845 0.1331 0.1660 0.1660 11,687,101
Dec 11, 2020 0.1450 0.1450 0.1162 0.1205 0.1205 6,417,829
Dec 10, 2020 0.0900 0.1465 0.0809 0.1450 0.1450 19,609,741
Lobe Sciences Ltd. has launched a preclinical research study using psilocybin and N-Acetylcysteine (“NAC”) for the treatment of mild traumatic brain injury/concussion (“mTBI”) with post-traumatic stress disorder (“PTSD”).
The study is in collaboration with a multidisciplinary team of scientists and physicians at the University of Miami's Miller School of Medicine under the lead of Michael E. Hoffer, M.D., professor of otolaryngology and neurological surgery.
https://www.lobesciences.com/technology
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM
Avant Technologies Launches Advanced AI Supercomputing Network and Expansive Data Solutions • AVAI • Apr 23, 2024 8:00 AM
BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM
Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • BLO • Apr 22, 2024 8:49 AM